RxDoctor Payments Data

Matthew Greives

Plastic Surgery · Houston, TXNPI 1811143613

Payments from drug & device makers

What this record shows

26 manufacturers reported payments, led by Novartis at 55.9% of the total. Reporting peaked in 2021 at $15,788 and has fallen 90.1% since, to $1,561 in 2025. Among plastic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,366in general payments, 2019–2025

Across 130 payments — averaging $202.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$15K
  • AbbVie$4K
  • Kls-martin L.p.$2K
  • Musculoskeletal Transplant Foundation Inc.$2K
  • Axogen$1K
  • Mentor Worldwide LLC$639
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$12,83849%
  • Food & beverage$13,52851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,366 in reported general payments places this provider in the 90th percentile of 337 plastic surgery providers in Texas.

See all plastic surgery providers in Texas

Other plastic surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →